When it comes to the use of PD-1 inhibitors in stomach cancer, the FDA has put its money where its mouth is. | After ...

A new immunotherapy for treating stomach cancer is helping people live 40% longer. However, some are affected by this ...

GERD and IBS both affect the digestive tract but have different symptoms and treatments. Learn how these two disorders affect ...

A recent trial reveals that durvalumab enhances event-free survival in patients with resectable gastric and gastroesophageal junction adenocarcinoma.